当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
Gardasil 9, Human Papillomavirus 9-valent Vaccine, Recombinant
申请企业
Merck Sharp & Dohme Corp.
药品名称
Gardasil 9, Human Papillomavirus 9-valent Vaccine, Recombinant
承诺描述
To conduct a 10-year study extension of Protocol V503-001 to evaluate the long-term safety, immunogenicity and effectiveness of Gardasil 9 in women who were 16 to 26 years of age at enrollment.